 |
|
plicamycin
An antibiotic isolated from the bacterium Streptomyces plicatus with antineoplastic activity. Plicamycin, also known as mithramycin, binds to the minor groove of DNA at GC-rich sites, resulting in inhibition of RNA synthesis; this agent also inhibits mRNA expression, resulting in a reduction in protein synthesis. In addition, plicamycin may inhibit bone resorption by down regulating transcription of c-src, an oncogene involved in bone metabolism and resorption. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | aureolic acid
mithramycin | | | | US brand name: | | Mithracin | | | | Foreign brand name: | | Mithracine | | | | Abbreviation: | | MTH | | | | Code names: | | A-2371
PA-144 | | |
|
|
